FDA Advisers Unanimously Support Over-the-Counter Birth Control Pill

FDA advisory panels have unanimously recommended making the birth control pill, Opill, available over the counter without a prescription, despite concerns about the quality of data used to support the switch. If approved, Opill would be the first birth control pill available for over-the-counter sales in the United States. Advocacy groups have been pushing for years for an over-the-counter birth control pill, and many major medical organizations support over-the-counter use. HRA Pharma, the French drugmaker behind Opill, said making birth control over the counter could prevent more than 37,000 unintended pregnancies in one year.